The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Osteoporosis in Patients With Diabetes Mellitus
Open accessAbstract
Demographic trends with longer life expectancy and a lifestyle characterized by low physical activity and high-energy food intake contribute to an increasing incidence of diabetes mellitus and osteoporosis. Diabetes mellitus is a risk factor for osteoporotic fractures. Patients with recent onset of type 1 diabetes mellitus may have impaired bone formation because of the absence of the anabolic effects of insulin and amylin, whereas in long-standing type 1 diabetes mellitus, vascular complications may account for low bone mass and increased fracture risk. Patients with type 2 diabetes mellitus display an increased fracture risk despite a higher BMD, which is mainly attributable to the increased risk of falling. Strategies to improve BMD and to prevent osteoporotic fractures in patients with type 1 diabetes mellitus may include optimal glycemic control and aggressive prevention and treatment of vascular complications. Patients with type 2 diabetes mellitus may additionally benefit from early visual assessment, regular exercise to improve muscle strength and balance, and specific measures for preventing falls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735
Prevention of falls and consequent injuries in elderly people
Kannus, P., Sievänen, H., Palvanen, M., Järvinen, T., & Parkkari, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67604-0 · Cited by 1,129
Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial
Bischoff, H. A., Stähelin, H. B., Dick, W., Akos, R., Knecht, M., Salis, C., Nebiker, M., Theiler, R., Pfeifer, M., Begerow, B., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.343 · Cited by 980
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813 · cited 12×
“Prevention and aggressive treatment of these complications by intensive insulin therapy, screening for low BMD, and awareness of other associated diseases (e.g., celiac disease) is recommended in patients with T1DM.”
BackgroundInfluentialThomas, T., Gori, F., Khosla, S., Jensen, M. D., Burguera, B., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.4.6637 · Cited by 726
The Molecular Clock Mediates Leptin-Regulated Bone Formation
Fu, L., Patel, M. S., Bradley, A., Wagner, E. F., & Karsenty, G. (2005) · Cell · doi:10.1016/j.cell.2005.06.028 · Cited by 578
Older Women With Diabetes Have a Higher Risk of Falls
Schwartz, A. V., Hillier, T. A., Sellmeyer, D. E., Resnick, H. E., Gregg, E., Ensrud, K. E., Schreiner, P. J., Margolis, K. L., Cauley, J. A., Nevitt, M. C., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1749 · Cited by 576
Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women
Nicodemus, K. K., & Folsom, A. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1192 · Cited by 568
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
de Liefde, I. I., van der Klift, M., de Laet, C. E. D. H., van Daele, P. L. A., Hofman, A., & Pols, H. A. P. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1909-1 · Cited by 555
Influence of nonenzymatic glycation on biomechanical properties of cortical bone
Vashishth, D., Gibson, G. J., Khoury, J. I., Schaffler, M. B., Kimura, J., & Fyhrie, D. P. (2001) · Bone · doi:10.1016/s8756-3282(00)00434-8 · Cited by 525
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2226 · Cited by 500
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Thrailkill, K. M., Lumpkin, C. K., Bunn, R. C., Kemp, S. F., & Fowlkes, J. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2005 · Cited by 490
Leptin Inhibits Osteoclast Generation
Holloway, W. R., Collier, F. M., Aitken, C. J., Myers, D. E., Hodge, J. M., Malakellis, M., Gough, T. J., Collier, G. R., & Prof. Nicholson, G. C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.200 · Cited by 440
Saito, M., Fujii, K., Mori, Y., & Marumo, K. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0155-5 · Cited by 436
Bone mineral density in patients with type 1 and type 2 diabetes.
Tuominen, J. T., Impivaara, O., Puukka, P., & Rönnemaa, T. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1196 · Cited by 392
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
Dittmar, M., & Kahaly, G. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021845 · Cited by 367 · cited 1×
“Multiorgan diseases caused by iron overload (in hereditary hemochromatosis) or autoimmune destruction (autoimmune polyglandular syndrome type 2) may result in pancreatic islet cell destruction resulting in secondary diabetes mellitus.((74,75)) Osteoporosis in these disorders is mainly caused by concurrent hypogonadism…”
BackgroundRecommendations for the Diagnosis and Management of Turner Syndrome1
Saenger, P., Wikland, K. A., Conway, G. S., Davenport, M., Gravholt, C. H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7683 · Cited by 351
Boscaro, M., Barzon, L., Fallo, F., & Sonino, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04172-6 · Cited by 350
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
Henriksen, D. B., Alexandersen, P., Bjarnason, N. H., Vilsbøll, T., Hartmann, B., Henriksen, E. E., Byrjalsen, I., Krarup, T., Holst, J. J., & Christiansen, C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2180 · Cited by 332
Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology
Kemink, S. A. G., Hermus, A. R. M. M., Swinkels, L. M. J. W., Lutterman, J. A., & Smals, A. G. H. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343726 · Cited by 325
Leptin Reduces Ovariectomy-Induced Bone Loss in Rats
Burguera, B. (2001) · Endocrinology · doi:10.1210/en.142.8.3546 · Cited by 316
Vitamin D, glucose tolerance and insulinaemia in elderly men
Baynes, K. C. R., Boucher, B. J., Feskens, E. J. M., & Kromhout, D. (1997) · Diabetologia · doi:10.1007/s001250050685 · Cited by 314
Adiponectin as a novel determinant of bone mineral density and visceral fat
Lenchik, L., Register, T. C., Hsu, F.-C., Lohman, K., Nicklas, B. J., Freedman, B. I., Langefeld, C. D., Carr, J. J., & Bowden, D. W. (2003) · Bone · doi:10.1016/s8756-3282(03)00237-0 · Cited by 306
Diabetes Mellitus: Does it Affect Bone?
Schwartz, A. V. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-0023-7 · Cited by 300
Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus
Scragg, R., Holdaway, I., Singh, V., Metcalf, P., Baker, J., & Dryson, E. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01040-k · Cited by 289
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways
Shinoda, Y., Yamaguchi, M., Ogata, N., Akune, T., Kubota, N., Yamauchi, T., Terauchi, Y., Kadowaki, T., Takeuchi, Y., Fukumoto, S., et al. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20890 · Cited by 284
Thomas, T., Burguera, B., Melton, L. J., Atkinson, E. J., O’Fallon, W. M., Riggs, B. L., & Khosla, S. (2001) · Bone · doi:10.1016/s8756-3282(01)00487-2 · Cited by 282
Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover
Ogata, N., Chikazu, D., Kubota, N., Terauchi, Y., Tobe, K., Azuma, Y., Ohta, T., Kadowaki, T., Nakamura, K., & Kawaguchi, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9017 · Cited by 271
Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors1
Bollag, R. J., Zhong, Q., Phillips, P., Min, L., Zhong, L., Cameron, R., Mulloy, A. L., Rasmussen, H., Qin, F., Ding, K. H., et al. (2000) · Endocrinology · doi:10.1210/endo.141.3.7366 · Cited by 265
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Schäffler, A., Müller-Ladner, U., Schölmerich, J., & Büchler, C. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0022 · Cited by 258
Barton, J. C., McDonnell, S. M., Adams, P. C., Brissot, P., Powell, L. W., Edwards, C. Q., Cook, J. D., Kowdley, K. V., & and The Hemochromatosis Management Working Group* (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00003 · Cited by 257
Bouillon, R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1194 · Cited by 244
Misra, A., & Garg, A. (2003) · Medicine · doi:10.1097/00005792-200303000-00007 · Cited by 241
Intensive Insulin Therapy and Bone Mineral Density in Type 1 Diabetes Mellitus: A Prospective Study
Campos Pastor, M. M., López-Ibarra, P. J., Escobar-Jiménez, F., Serrano Pardo, M. D., & García-Cervigón, A. (2000) · Osteoporosis International · doi:10.1007/s001980070114 · Cited by 223
Strotmeyer, E. S., Cauley, J. A., Schwartz, A. V., Nevitt, M. C., Resnick, H. E., Zmuda, J. M., Bauer, D. C., Tylavsky, F. A., de Rekeneire, N., Harris, T. B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040311 · Cited by 218
Dobnig, H., Piswanger-Sölkner, J. C., Roth, M., Obermayer-Pietsch, B., Tiran, A., Strele, A., Maier, E., Maritschnegg, P., Sieberer, C., & Fahrleitner-Pammer, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0460 · Cited by 217
Self-citation[Management of hemochromatosis].
Régent, L. (2007) · PubMed · Cited by 209
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312135 · Cited by 206 · cited 1×
“The phenotype of amylin-deficient mice is characterized by osteopenia and enhanced bone resorption, and amylin was found to inhibit osteoclastogenesis in vitro.((34))”
BackgroundThommesen, L., Stunes, A. K., Monjo, M., Grøsvik, K., Tamburstuen, M. V., Kjøbli, E., Lyngstadaas, S. P., Reseland, J. E., & Syversen, U. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20915 · Cited by 205
Gerdhem, P., Isaksson, A., Åkesson, K., & Obrant, K. J. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1877-5 · Cited by 204
Diabetes mellitus a risk for osteoporosis?
Leidig-Bruckner, G., & Ziegler, R. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18605 · Cited by 190
What Can Progeroid Syndromes Tell Us About Human Aging?
Kipling, D., Davis, T., Ostler, E. L., & Faragher, R. G. A. (2004) · Science · doi:10.1126/science.1102587 · Cited by 183
Muñoz-Torres, M., Jódar, E., Escobar-Jiménez, F., López-Ibarra, P. J., & Luna, J. D. (1996) · Calcified Tissue International · doi:10.1007/bf02509378 · Cited by 176
Endocrine dysfunction in Kearns‐Sayre syndrome
Harvey, J. N., & Barnett, D. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02289.x · Cited by 173
Osteoprotegerin ligand: a regulator of immune responses and bone physiology
Kong, Y.-Y., Boyle, W. J., & Penninger, J. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01718-7 · Cited by 162
Wakasugi, M., Wakao, R., Tawata, M., Gan, N., Koizumi, K., & Onaya, T. (1993) · Bone · doi:10.1016/8756-3282(93)90252-6 · Cited by 159
Okazaki, R., Totsuka, Y., Hamano, K., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4258 · Cited by 144
Osteoporosis and Klinefelter's syndrome
Horowitz, M., Wishart, J. M., O’Loughlin, P. D., Morris, H. A., Needt, A. G., & Nordin, B. E. C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02910.x · Cited by 143
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
Bollag, R. J., Zhong, Q., Ding, K., Phillips, P., Zhong, L., Qin, F., Cranford, J., Mulloy, A. L., Cameron, R. S., & Isales, C. M. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00405-1 · Cited by 142
Valerio, G., PUENTE, A. D., Puente, A. E.-D., Buono, P., Mozzillo, E., & Franzese, A. (2002) · Hormone Research in Paediatrics · doi:10.1159/000066441 · Cited by 142
Akune, T., Ogata, N., Hoshi, K., Kubota, N., Terauchi, Y., Tobe, K., Takagi, H., Azuma, Y., Kadowaki, T., Nakamura, K., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204046 · Cited by 141
Hampson, G., Evans, C., Petitt, R. J., Evans, W. D., Woodhead, S. J., Peters, J. R., & Ralston, S. H. (1998) · Diabetologia · doi:10.1007/s001250051071 · Cited by 137
Impact of peripheral neuropathy on bone density in patients with type 1 diabetes.
Rix, M., Andreassen, H. F., & Eskildsen, P. C. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.827 · Cited by 137
The mineral and mechanical properties of bone in chronic experimental diabetes
Einhorn, T. A., Boskey, A. L., Gundberg, C. M., Vigorita, V. J., Devlin, V. J., & Beyer, M. M. (1988) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100060303 · Cited by 136
Günczler, P., Lanes, R., PAZ-MARTINEZ, V., Martinis, R., Esaa, S., Colmenares, V., & Weisinger, J. R. (1998) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1998.11.3.413 · Cited by 134
Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey
Gravholt, C. H., Vestergaard, P., Hermann, A. P., Mosekilde, L., Brixen, K., & Christiansen, J. S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01807.x · Cited by 130
Bone Mineral Density at Time Of Clinical Diagnosis of Adult-Onset Type 1 Diabetes Mellitus
López-Ibarra, P. J., Pastor, M. M. C., Escobar‐Jiménez, F., Pardo, M. D. S., González, A. G., Luna, J. D. D., Requena, M. E. R., & Aguilar‐Diosdado, M. (2001) · Endocrine Practice · doi:10.4158/ep.7.5.346 · Cited by 130
Amylin and Bone Metabolism in Streptozotocin-Induced Diabetic Rats
Horcajada-Molteni, M.-N., Chanteranne, B., Lebecque, P., Davicco, M.-J., Coxam, V., Young, A., & Barlet, J.-P. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.5.958 · Cited by 118
Osteoporosis and Diabetes Mellitus
Inzerillo, A. M., & Epstein, S. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000032415.83124.20 · Cited by 117
Regulation of Osteoclastic Bone Resorption by Glucose
Williams, J. P., Blair, H. C., McDonald, J. M., McKenna, M. A., Jordan, S. E., Williford, J., & Hardy, R. W. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6795 · Cited by 109
Does Low Bone Mineral Density Start in Post-Teenage Years in Women With Type 1 Diabetes?
Liu, E. Y., Wactawski‐Wende, J., Donahue, R. P., Dmochowski, J., Hovey, K. M. O., & Quattrin, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2365 · Cited by 109
Strotmeyer, E. S., Cauley, J. A., Orchard, T. J., Steenkiste, A. R., & Dorman, J. S. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1353 · Cited by 108
Bone metabolism in type 2 diabetes mellitus
Isaia, G., Ardissone, P., Stefano, M. D., Ferrari, D., Martina, V., Porta, M., Tagliabue, M., & Molinatti, G. M. (1999) · Acta Diabetologica · doi:10.1007/s005920050142 · Cited by 105
Majima, T., Komatsu, Y., Yamada, T., Koike, Y., Shigemoto, M., Takagi, C., Hatanaka, I., & Nakao, K. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1786-z · Cited by 105
Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling
Jiang, J. Q., Lichtler, A. C., Gronowicz, G., Adams, D. J., Clark, S. H., Rosen, C. J., & Kream, B. E. (2006) · Bone · doi:10.1016/j.bone.2006.02.068 · Cited by 96
Influence of diabetes on peripheral bone mineral density in men: a controlled study
Bridges, M., Moochhala, S. H., Barbour, J., & Kelly, C. A. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0183-1 · Cited by 94
Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus
Olmos, J. M., Pérez‐Castrillón, J. L., García, M. T. S., Garrido, J. C., Amado, J. A., & González-Macı́as, J. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80157-2 · Cited by 87
Potential Role of Pancreatic and Enteric Hormones in Regulating Bone Turnover
Clowes, J. A., Khosla, S., & Eastell, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050524 · Cited by 86
Bouxsein, M., Rosen, C. J., Turner, C. H., Ackert, C. L., Shultz, K. L., Donahue, L. R., Churchill, G. A., Adamo, M. L., Powell, D. R., Turner, R. T., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.570 · Cited by 79
Body composition and bone mineral density in long‐standing type 1 diabetes
Ingberg, C. M., Palmér, M., Åman, J., Arvidsson, B., Schvarcz, E., & Berne, C. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01283.x · Cited by 65
Maor, G., & Karnieli, E. (1999) · Endocrinology · doi:10.1210/en.140.4.1841 · Cited by 65
Lunt, H., Florkowski, C. M., Cundy, T., Kendall, D., Brown, L., Elliot, J. R., Wells, J. E., & Turner, J. G. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00012-6 · Cited by 54
Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors.
Pérez-Castrillón, J., de Luis, D., Martín-Escudero, J., Asensio, T., Delamo, R., & Izaola, O. (2004) · Journal of diabetes and its complications · doi:10.1016/s1056-8727(03)00072-2 · Cited by 49
Bone mineral density in patients with type 1 diabetes mellitus.
Rozadilla, A., Solé, J. M. N., Montaña, E., Fiter, J., Gómez‐Vaquero, C., Soler, J., & Roig-Escofet, D. (2000) · PubMed · Cited by 47
Mosaic analysis of insulin receptor function
Kitamura, T., Kitamura, Y., Nakae, J., Giordano, A., Cinti, S., Kahn, C. R., Efstratiadis, A., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17810 · Cited by 42
Calcium Homeostasis During Oral Glucose Load in Healthy Women
D'Erasmo, E., Pisani, D., Ragno, A., et al. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978731 · Cited by 34
Lövestam-Adrian (1997) · Research Portal (Queen's University Belfast) · doi:10.1002/(sici)1096-9136(199712)14:12 · Cited by 4
Cited by
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Rogers, L. C., Frykberg, R. G., Armstrong, D. G., Boulton, A. J. M., Edmonds, M., Van, G. H., Hartemann, A., Game, F., Jeffcoate, W., Jirkovska, A., et al. (2011) · Diabetes Care · doi:10.2337/dc11-0844 · Cited by 567
The multifaceted role of fibrinogen in tissue injury and inflammation
Luyendyk, J. P., Schoenecker, J. G., & Flick, M. J. (2019) · Blood · doi:10.1182/blood-2018-07-818211 · Cited by 555
Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study
Melton, L. J., Leibson, C. L., Achenbach, S. J., Therneau, T. M., & Khosla, S. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080323 · Cited by 416
Bone, sweet bone—osteoporotic fractures in diabetes mellitus
Hamann, C., Kirschner, S., Günther, K.-P., & Hofbauer, L. C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.233 · Cited by 380
Self-citation
Metadata
- Authors
- Hofbauer, L. C., Brueck, C. C., Singh, S. K., & Dobnig, H.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-01
- Volume
- 22
- Issue
- 9
- Pages
- 1317-1328
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2155821999
- Cited by
- 503
- References
- 80
- FWCI
- 26.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.